Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.25
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $20.0M | $74.7K | $0 | $95.3K |
| Cost of revenue | $176.0K | $58.9K | $17.2K | $0 | $0 | $0 | $0 | $0 |
| Gross profit | −$176.0K | −$58.9K | −$17.2K | $0 | $20.0M | $74.7K | $0 | $95.3K |
| Gross margin | — | — | — | — | 100.0% | 100.0% | — | 100.0% |
| R&D | $13.3M | $3.7M | $0 | $1.8K | $610 | $0 | $0 | $0 |
| Operating income | −$24.8M | −$8.6M | −$3.2M | −$3.0M | $18.3M | −$628.0K | −$148.0K | −$268.0K |
| EBITDA | −$24.6M | −$7.5M | −$3.2M | −$3.0M | $18.5M | −$421.7K | −$10.0M | −$4.5M |
| Net income | −$25.2M | −$11.6M | −$4.4M | −$10.6M | $18.4M | −$628.0K | −$10.2M | −$4.8M |
| Net margin | — | — | — | — | 91.9% | -840.7% | — | -4995.2% |
| EPS (diluted) | -4.17 | -0.15 | -0.07 | -0.05 | 0.07 | -0.00 | -0.02 | -0.01 |
Annual figures · source: Financial Modeling Prep
AMARANTUS BIOSCIENCE HLDG
No one on the platform currently holds AMBS.
No tracked institution reports a position in AMBS as of their last filing.
| Execution date | Ratio |
|---|---|
| 2015-06-10 | 1-for-150reverse |
| 2011-06-14 | 25-for-1 |
No one on the platform has traded AMBS yet.
| $35450 |
| — |
| ENDVEndonovo Therapeutics, Inc. | $0.00 | +0.00% | $31875 | — |
| IBXGiBX Group, Inc. | $0.00 | +0.00% | $1975 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$AMBS The transaction was fake- they made everything up. This company is nothing more than a velvet painting of a dolphin and a whale getting it on.
View on StockTwits ↗$AMBS What happened with this transaction? 2021-2022: Focused on MANF (Mesencephalic Astrocyte-Derived Neurotrophic Factor) platform for neurodegenerative/ophthalmic diseases, entering deals with Merck for chaperone activator discovery and licensing MANF assets.
View on StockTwits ↗$TOMDF $AMBS looks like many of the old Todos Med leaders formed TolloHealth in Tampa? Maybe just selling Dr Arad's products for her as a distributor? I'm pretty sure Dr Arad walked away with the IP for Tollovid when Todos folded https://tollohealth.com/about/
View on StockTwits ↗$AEON $CDIO $SANA $AMBS $EOLS $AEON PUBLIC FLOAT 7.68 MILLION TWO CONFIRMED 5% SHAREHOLDERS NEW CEO BOUGHT 59,000 SHARES 25 YEARS EXPERIENCE 10 MILLION CASH upcoming conference MAY 19 th $1.00-5.00 PRICE TARGET $360.00
View on StockTwits ↗$AEON $CDIO $SANA $AMBS LETS GO….$AEON MOVE IT $1.00 plus PARTNER $EOLS 10 MILLION CASH NEW CEO 25 YEARS EXPERIENCE FDA RESULTS AND MEETING ON ALREADY APPROVED MARKETED DRUG
View on StockTwits ↗@hesmybitch @deekay99 Go back to pumping $AMBS. It‘s fallen to $0 .00 and can’t get up.
View on StockTwits ↗$OSTX You’ve been warned… Gerald C is employed here… he crippled two other of his companies…. $AMBS $TOMDF
View on StockTwits ↗$OSTX Gerald C taking your money, told ya… Dilution is his game…. You’ve been warned …. Two companies he did this to…. $TOMDF $AMBS
View on StockTwits ↗$OSTX Gerald C gonna suck this stock dry… Warning will warning…. $AMBS $TOMDF both of his fails
View on StockTwits ↗$OSTX Gerald C is employeed here This will surely fail…. He ran two other companies to the ground…. $TOMDF $AMBS
View on StockTwits ↗$AMBS what's going on here? Hyperion loves waking up to a 4,000,000% gain!! Coming back to life???
View on StockTwits ↗$AMBS $RGBP $TOMDF $USEI, I wonder how many have been delisted since?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.